About Us
Overview
Our Vision & Values
Milestones
Leadership
Awards & Recognition
CSR
Our Business
Overview
Formulations
Biologics
APIs
Research
Overview
Formulations
APIs
R&D Locations
Manufacturing
Investors
Financials and Reports
Share, Governance and Investor Services
Offer Documents
Disclosures Under Regulation 46 of SEBI (LODR) Regulations
Other Disclosures
Media
Care
Careers
Newsroom
Contact Us
Disclosures Under Regulation 46 of SEBI (LODR) Regulations
Share, Governance and Investor Services | Emcure Pharmaceuticals New
Filings | Emcure Pharmaceuticals
Disclosures Under Regulation 46 of SEBI (LODR) Regulations
Other Disclosures
Offer Documents
Media
Shareholding Pattern
Shareholding Pattern for Prelisting
Download
Disclosure under Regulation 30
Intimation under Regulation 30 – Incorporation of wholly-owned Subsidiary – Emcutix Biopharmaceuticals Limited
03.10.2024
Download
Intimation under Regulation 30 – Proposed Incorporation of Wholly-owned Subsidiary
13.09.2024
Download
Audio recording of Earning call - Q1 FY 25
Download
Outcome of Board Meeting & Financial Results Q1 FY25
Download
Intimation under Regulation 30 – Revision in Credit Rating – CRISIL
13.08.2024
Download
Intimation under Regulation 30 – Revision in Credit Ratings – CARE
13.08.2024
Download
Intimation under Regulation 30(5) – Details of KMPs
Download
Intimation under Regulation 30 - Acquisition
25.07.2024
Download
Board Meeting Intimations
Board Meeting Intimation for Q1 FY 2024-25
Download
Financial Information
Quarterly Financials – Q1 FY25
Download
Annual Reports
Annual Report of FY 2023-24
Download
Credit Ratings
Credit Ratings
Download
Investor Information
Investor/ Analyst Calls
Transcript of Earnings Call - Q1 FY25
Download
Intimation for Earnings Call - Q1 FY25
Download
Audio recording of Earnings Call - Q1 FY25
Download
Newspaper Advertisements
Newspaper Publication of Unaudited Financial Results - Q1 FY25
Download
Investors Presentations
Quick Explore
About Us
Career
Financials
Contact Us
Manufacturing
Our Business
Newsroom
